Prenetics Global Ltd - Class A Ordinary Shares, par value $0.0015 per share (PRE)

CUSIP: G72245122

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 5 signals
Share change
+1,172
SEC-reported price per share
$23.13
Number of holders
3
Value change
+$27,108
Number of buys
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
14,813,848

Security key

G72245122

Report period

Q3 2026

Institutions

3

Top holders

3

Ownership snapshot

Top reported holders of PRE - Prenetics Global Ltd - Class A Ordinary Shares, par value $0.0015 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
EASTSPRING INVESTMENTS (S...
Disclosed value leader
Genetel Bioventures Ltd
Comparable rows
15/15
Latest evidence
24 Aug 2026
13D/G 3/4/5 13F Lead comparable stake: 3.8% 13D/G row: EASTSPRING INVESTMENTS (SINGAPORE) LTD Showing 1-6 of 15 holder rows.

Quick read

EASTSPRING INVESTMENTS (SINGAPORE) LTD leads the comparable SEC ownership view at 3.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens EASTSPRING INVESTMENTS (SINGAPORE) LTD's linked filing trail.
Comparable ownership Top 5
EASTSPRING INVESTMENTS (SINGAPORE... 3.8%
Genetel Bioventures Ltd 3.3%
David Eric Vanderveen 0.32%
Brian Joseph Rosin 0.16%
Darshan Ravindra Shah 0.03%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
EASTSPRING INVESTMENTS (SINGAPORE) LTD
13D/G
EASTSPRING INVESTMENTS (SINGAPORE) LIMITED
3.8%
$2,225,408
427,963 shares
$0 30 Sep 2024
Genetel Bioventures Ltd
13D/G
3.3%
$9,444,962
488,857 shares
$0 31 Mar 2026
David Eric Vanderveen
3/4/5
Director
0.32%
$902,127
46,897 shares
— 15 Jun 2026
Brian Joseph Rosin
3/4/5
CFO of IM8 (US) LLC
0.16%
$526,680
23,100 shares
+$497,700 24 Aug 2026
Darshan Ravindra Shah
3/4/5
Director
0.03%
$70,969
4,506 shares
— 26 Mar 2026
Prospect Capital Advisors, LLC
13F
Company
13F
1.6%
$4,508,496
235,800 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
3
Shares
1,197
Rows available
3
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q3 2025 Across Filers

Q3 2025 holders
15
Q3 2026 holders
3
Holder diff
-12
Investor Q3 2025 Shares Q3 2026 Shares Share Diff Share Chg % Q3 2025 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .